TMO
Thermo Fisher Scientific Inc
NYSE: TMO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$478.96
+2.72% today
Updated 2026-04-30
Market cap
$173.27B
P/E ratio
25.65
P/S ratio
3.83x
EPS (TTM)
$18.18
Dividend yield
0.37%
52W range
$384 – $643
Volume
2.0M
Thermo Fisher Scientific Inc (TMO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $21.26B | $21.21B | $21.09B | $21.60B | $21.39B | $26.83B | $27.44B | $31.86B | $42.85B | $40.83B | $45.91B | $56.67B | $56.23B | $58.38B | $69.05B | $95.12B | $97.15B | $98.73B | $97.32B | $110.34B |
| Cash & equivalents | $667.43M | $625.10M | $1.28B | $1.56B | $917.10M | $1.02B | $805.60M | $5.83B | $1.34B | $452.10M | $786.00M | $1.33B | $2.10B | $2.40B | $10.32B | $4.48B | $8.52B | $8.08B | $4.01B | $9.85B |
| Current assets | $3.66B | $3.67B | $4.35B | $4.53B | $4.14B | $4.82B | $4.83B | $9.88B | $6.54B | $5.74B | $7.02B | $9.42B | $10.63B | $11.89B | $21.96B | $20.11B | $25.23B | $24.59B | $22.14B | $28.71B |
| Total liabilities | $7.35B | $6.72B | $6.16B | $6.17B | $6.03B | $11.80B | $11.98B | $15.01B | $22.30B | $19.48B | $24.37B | $31.26B | $28.65B | $28.71B | $34.53B | $54.15B | $53.01B | $51.88B | $47.65B | $56.81B |
| Current liabilities | $2.15B | $1.90B | $1.54B | $1.64B | $1.74B | $3.09B | $2.09B | $3.13B | $5.35B | $4.15B | $4.87B | $7.05B | $6.15B | $6.20B | $10.30B | $13.44B | $17.01B | $14.01B | $13.33B | $15.19B |
| Long-term debt | $2.18B | $2.05B | $2.04B | $2.07B | $2.03B | $5.76B | $7.03B | $9.50B | $12.35B | $11.42B | $15.37B | $18.87B | $17.72B | $17.08B | $19.11B | $32.33B | $28.91B | $31.31B | $29.06B | $35.85B |
| Shareholder equity | $13.91B | $14.49B | $14.93B | $15.43B | $15.36B | $15.04B | $15.46B | $16.86B | $20.55B | $21.35B | $21.54B | $25.41B | $27.59B | $29.68B | $34.51B | $40.79B | $43.98B | $46.73B | $49.58B | $53.41B |
| Retained earnings | $1.77B | $2.53B | $3.53B | $4.35B | $5.39B | $6.72B | $7.70B | $8.75B | $10.41B | $12.14B | $13.93B | $15.91B | $18.70B | $22.09B | $28.12B | $35.43B | $41.91B | $47.36B | $53.10B | — |
| Accounts receivable | $1.39B | $1.45B | $1.48B | $1.41B | $1.52B | $1.76B | $1.80B | $1.94B | $2.47B | $2.54B | $3.05B | $3.88B | $4.59B | $4.95B | $6.47B | $8.95B | $9.43B | $9.66B | $9.63B | $8.90B |
| Inventory | $1.16B | $1.17B | $1.17B | $1.13B | $1.18B | $1.36B | $1.44B | $1.49B | $1.86B | $1.99B | $2.21B | $2.97B | $3.00B | $3.37B | $4.03B | $5.05B | $5.63B | $5.09B | $4.98B | $5.42B |
| Goodwill | $8.52B | $8.71B | $8.68B | $8.98B | $9.27B | $11.99B | $12.47B | $12.50B | $18.84B | $18.83B | $21.33B | $25.29B | $25.35B | $25.71B | $26.04B | $41.92B | $41.20B | $44.02B | $45.85B | $49.36B |